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Radiotherapy is the primary line of cancer treatment for cervical cancer and is known to induce cell death in tumors.
Radiotherapy is however limited by the total dose that can be given without damaging normal tissue. Plumbagin, a
naturally occurring naphthaquinone, has been reported to have free radical producing properties. Hence we
hypothesized that plumbagin could also have properties that could modify effects of radiation on cervical cancer cells.
Radiation in combination with plumbagin may thus have treatment augmenting effects. Results from our studies have
shown that a lower dose of radiation in combination with plumbagin could induce apoptosis more effectively
compared to a higher dose of radiation alone. Plumbagin in combination with 2 Gy of radiation was very effective in
inducing apoptosis, when compared to a higher radiation dose of 10 Gy alone. This combination also showed a
fivefold increase in the activation of caspase 3 in C33A cells. Activation of effector caspases confirms that the
induction of apoptosis by irradiation and plumbagin involves caspase-dependent pathways. Expression of apoptotic
regulatory molecules Bcl-2, Bax and Survivin was also modulated by plumbagin in combination with radiation. In
summary, this study shows that a combination of plumbagin and radiation augmented cell growth inhibition
compared to higher radiation dose alone, thus indicating that plumbagin may be a potential radiosensitizer acting
through the induction of apoptosis.  2007 Wiley-Liss, Inc.
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INTRODUCTION
Cancer of the uterine cervix is the second leading
cause of death from cancer in women worldwide [1].
Radiotherapy is an important treatmentmodality for
cervical cancer, particularly for locally advanced
tumors and is known to mainly induce cell death in
tumors. Radiotherapy is limitedby the totaldose that
can be given without damaging normal tissue. Any
compound that increases the therapeutic efficacy of
radiation without dose escalation (that is higher
treatment response at lower doses) will therefore be
beneficial for cancer treatment. Hence the study of
such biological responsemodifiers is a prime require-
ment in cancer therapeutics. Quinones represent
the largest class of quinoid compounds, which are
widely distributed in nature. Plumbagin (5-hydroxy-
2-methyl-1,4-naphthoquinone), a naturally occurring
naphthoquinone derivative from plants belonging
to Plumbaginaceae and Droseraceae families, has
been reported to possess anticancer activity [2–5].
Besides anticancer effects, plumbagin also exhibited
radiosensitizing properties in experimental mouse
tumors as well as in tumor cells in vitro [6–8].
However, its cellular mechanism and extent of
radiosensitization has not been studied and thus
formed thebasis of this study.This study shows that a
combination of plumbagin and radiation augmen-
ted cell growth inhibition when compared to a
higher radiation dose, thus indicating that plumba-
ginmaybe a potential radiosensitizer acting through
the induction of apoptosis.
MATERIALS AND METHODS
Chemicals
Plumbagin was purchased from Sigma (St. Louis,
MO). Stock solution of plumbagin was made in
dimethyl sulphoxide (DMSO) (Sigma). The final
concentration of DMSO for all treatments was less
than 0.1%. The antibody against Survivin was
purchased from Santa Cruz Biotechnology (Santa
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Cruz Biotechnology, Inc., CA); those against Bcl-2
and Bax were obtained from Imgenex (San Diego,
CA) and those against caspase 3, 8 and 9 from Cell
Signalling, Inc. (Beverly, MA). Dulbecco’s modified
Eagle’s medium (DMEM), fetal bovine serum (FBS),
custom synthesized primers for RT-PCR and TRI
reagent for RNA isolation were purchased from
Sigma. MTT (3-(4,5-dimethylthiazol-2yl)-2,5-diphe-
nyltetrazolium bromide), was obtained from
Himedia (Mumbai, India), ethidium bromide and
acridine orange were purchased from Bangalore
Genei (Bangalore, India) while TUNEL kits and
RT-PCR reagents were purchased from Promega
(Madison, WI).
Cell Lines
Human cervical cancer cell lines, HeLa (HPV18
positive), SiHa (HPV16 positive), C33A (HPV nega-
tive) and breast adenocarcinoma cells, MCF 7 and
normalbreast epithelial cells,HBL100were obtained
fromNationalCentre forCell Sciences (NCCS), Pune,
India. The cells were maintained in DMEM supple-
mented with 10% FBS.
Treatment
Cells were irradiated with gamma rays from a
Theratron 780C machine at a dose rate of 266 cGy/
min. Cells were treated with different doses of
radiation (2, 4, 6, 8 and 10 Gy) and with different
concentrations (750 nM, 1 mM, 2.5 mM) of plumba-
gin. To study the combined effect of plumbagin and
radiation we did pretreatment with plumbagin
before irradiation, co-treatment of plumbagin and
radiation and also replenishment of plumbagin after
irradiation. Co-treatment of plumbagin with radia-
tion was found to be most effective in inducing
maximum cell death. Different combinations of
plumbagin and radiation were tried and the treat-
ments finalized were 750 nM plumbagin, 2, 10 Gy
and a combination of 750 nM plumbagin with 2 Gy
radiation, for all the experiments. For combined
treatment, cells were treated with plumbagin 1 h
before irradiation. TheMTTassaywas done 48hafter
the respective treatments and all the other experi-
ments were done 12 h after treatment.
Cytotoxicity Assay
Cytotoxic effect of plumbagin on cervical cancer
cells was detected byMTT (3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazoliumbromide) assay as describ-
ed earlier [9]. To assess whether the cytotoxicity of
plumbagin is specific for cancer cells, we compared
the cytotoxicity of plumbagin on human breast
adenocarcinoma cells, MCF 7 and human breast
epithelial cells, HBL 100. The experiments were
performed in triplicate. Cell survival was expressed
as percentage over the untreated control.
Acridine Orange–Ethidium Bromide Staining for
Morphological Evaluation of Apoptosis
Characteristic apoptotic morphological changes
were assessed by fluorescent microscopy, with an
acridine orange and ethidium bromide staining
method as described earlier [9]. Acridine orange/
ethidium bromide staining uses combination of two
dyes to visualize cells with aberrant chromatin
organization. Acridine orange was used to visualize
the number of cells which has undergone apoptosis,
but it cannot distinguish viable from non-viable
cells. To achieve this, a mixture of acridine orange
and ethidium bromide was used. The differential
uptake of these two dyes allows the identification of
viable and non-viable cells.
Terminal Deoxynucleotidyl Transferase-Mediated Biotin
dUTP Nick End Labeling Assay (TUNEL)
To further confirm apoptotic cells, in situ end
labeling of the 30OH end of the DNA fragments
generated by apoptosis-associated endonucleases
was performed by using the Dead End apoptosis
detection kit (Promega, Madison, WI), according to
the manufacturer’s protocol.
Loss of Mitochondrial Membrane Potential
This was primarily done according to the protocol
supplied by the manufacturers of ApoAlertTM
Mitochondrial membrane sensor kit (BD Biosciences
Clontech, PaloAlto, CA). MitoSensor aggregates in
themitochondria of healthy cells and fluoresces red.
In apoptotic cells the mitochondrial potential is
altered and MitoSensor cannot accumulate in mito-
chondria and remain in the cytoplasmandfluoresces
green.
Caspase Activation
The enzymatic activity of caspase 3, caspase 6,
caspase 8 and caspase 9 induced by the plumbagin
and/or radiation was assayed spectrofluorimetri-
cally. The experiments were performed in triplicate.
Briefly, cells were cultured in 90 mm culture plates
(2.5106 cells/plate). The cells were treatedwith the
indicated concentrations of the drug/dose of radia-
tion and incubated for 12 h. The cells were scraped
forwhole cell lysate preparation. Fiftymicrograms of
total protein was incubated with 50 mMof caspase 3,
caspase 6, caspase 8 or caspase 9, flourimetric
substrate in a total volume of 500 ml of reaction
buffer at 378C for 1 h in the dark. The released AMC
was quantitated using spectrofluorimeter (LS-50B
model, Perkin Elmer, MA) with excitation and emis-
sion wavelengths 400 and 505 nm, respectively.
Reverse Transcription Polymerase Chain Reaction
(RT-PCR) for Bcl-2, Bax, Survivin and b-2-microglobulin
Cells were cultured in 90 mm culture plates
(2.5106 cells/plate) and treated with or without
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different concentrations of plumbagin and/or differ-
entdosesof radiation for12h.TotalRNAwas isolated
from them using TRI reagent according to the
manufacturer’s recommendations. Five micrograms
of total RNA extracted were subjected to cDNA
synthesis at 378C in a 25 ml reaction mix containing
200 U of MMLV Reverse transcriptase in 1 reaction
buffer with 2 mg of random hexamer; 6 U of
RNAasein; 100 mM dNTP mix for 1 h. The enzyme
was inactivated at 908C for 4 min and quick chilled.
Threemicroliters of cDNAwas used for RT-PCR for
genes Bcl-2, Bax, Survivin and b-2-microglobulin. Each
PCRcycle consistedof an initial denaturationat948C
for 3 min, followed by melting at 948C for 30 s,
annealing (Table 1) for 40 s and extension at 728C for
90 s and at the end of 35 cycles a final extension at
728C for 3 min for Bcl-2, Bax and Survivin. The PCR
cycle for b-2-microglobulin consisted of an initial
denaturation at 95 for 2 min, followed by melting
at 948C for 1 min, annealing (Table 1) for 30 s and
extension at 728Cfor 30 s andat the endof 38 cycles a
final extension at 728C for 2 min. Expression values
for each PCR product were normalized to their
respective b-2-microglobulin expression.
Western Blot Analysis for Bcl-2, Bax, Survivin,
Caspases 3, 8 and 9
Cells were cultured in 90 mm culture plates
(2.5106 cells/plate) and treated with or without
different concentrations of plumbagin and/or differ-
ent doses of radiation for 12 h. Western blotting was
done using 50 mg of total protein for the detection of
protein levels of Bcl-2, Bax, Survivin, Caspases 3, 8
and 9. Total protein was extracted from monolayer
cells treated with and without plumbagin and/or
radiation as described earlier [9]. Densitometric
analysis of the bands was done and normalized with
b-actin.
Statistical Analysis
All statistical calculations were carried out with
the Statistical Package for Social Sciences (SPSS) soft-
wareprogram.Values are expressed as themean SE.
The differences among themean values from at least
three independent experiments were analyzed with
one-way ANOVA followed by Tukey post hoc t-test
analysis. Differences between means were consid-
ered statistically significant at P<0.05.
RESULTS
Plumbagin in Combination With Radiation Augmented
Cell Growth Inhibition in Cervical Cancer Cells
Plumbagin induced cytotoxicity inHeLa, SiHa and
C33A cells in a time and concentration-dependent
manner (Figure 1A). C33A cells were found to be
more sensitive to radiation and plumbagin. A
combination of 2 Gy radiation with 750 nM
plumbagin augmented the cell growth inhibition
more effectively than a radiation dose of 10Gy. SiHa
and C33A cells were sensitive to a combination of
750 nM plumbagin and 2 Gy of radiation, cell
viability wasmarkedly lower than on treatmentwith
10 Gy of radiation (P<0.001) (Figure 1B). The
radiosensitizing effect of a combination of 2 Gy
radiation and 750 nM plumbagin on the cells is a
synergistic effect. This was confirmed by calculating
the fractional inhibitory concentration (FIC) [10].
Cell viability inHeLa cells after treatmentwith 10Gy
and a combination of 750 nM plumbagin and 2 Gy
irradiation was almost the same (Figure 1B). Our
results suggest that the radiosensitizing action of
plumbagin was most effective in the C33A cells.
A comparative analysis of the cytotoxicity of
plumbagin on human breast epithelial cells, HBL
100 andhumanbreast adenocarcinoma cells,MCF7;
showed that cell death induced by 5 mM plumbagin
in the cancer cells was almost threefold higher than
in the HBL-100 cells.
Plumbagin and/or Radiation Induce Apoptosis Most
Effectively in C33A Cells
To confirm whether the cytotoxic effects induced
by plumbagin in these cells involves apoptotic
changes, cervical cancer cells were treated with
plumbagin and/or radiation for 12 h and stained
with acridine orange–ethidium bromide. The num-
ber of apoptotic cells was highest when treated with
a combination of 750 nM plumbagin and 2 Gy
radiation in all the three cell lines (Figure 2). TUNEL
positive nuclei were also highest when treated with
a combination of 750 nM plumbagin and 2 Gy
Table 1. Primer Sequence
Target gene Primer sequence
Amplicon
size (bp)
Annealing
temperature (8C)
Bcl-2 F: 50GCTTTTCCTCTGGGAAGGAT30;
R: 50ATCCCACTCGTAGCCCCTCT30
111 63
Bax F: 50TGCCTCAGGATGCGTCCACC30;
R: 50ACTCGGAAAAAGACCTCTCGG30
136 60
Survivin F: 50ATGGGTGCCCCGACGTTGCC30;
R: 50AAGGAAAGCGCAACCGGACG30
262 59
b-2-Microglobulin F: 50AAGAGAGGCATCCTCACCCT30;
R: 50TACATGGCTGGGGTGTTGAA30
124 50
24 NAIR ET AL.
Molecular Carcinogenesis DOI 10.1002/mc
radiation in all the three cell lines (Figure 3). Similar
results were obtained while assessing the loss of
mitochondrial membrane potential (Figure 4).
Activation of Effector Caspases Confirms That the
Mode of Action of Irradiation and Plumbagin Involves
Caspase-Dependent Pathways of Apoptosis
Caspases are a family of cysteine proteases that are
activated during the execution phase of the apopto-
tic process. Activation of caspases 3, 6, 8 and 9 was
assessed by the spectrofluorimetric caspase activa-
tionassay. Activationof all the caspases analyzedwas
greater on combination treatment when compared
to a radiation dose of 10 Gy in both C33A and SiHa
cells (P<0.001). Although HeLa cells showed an
insignificant increase in activation of caspases 6,
8 and 9, activation of caspase 3 was lower on
combination treatment than 10 Gy. The combina-
tion dose showed a fivefold increase in the activation
of caspase 3 in C33A cells (P< 0.001) (Figure 5C).
Activation of caspases inC33A cells was confirmed
by Western blotting. The cleaved active bands of
caspases 3, 8 and 9 were observed, after all the four
treatments. The cleavedactivebandsof caspase8and
caspase 3 were observed as very intense bands in the
samples treated with the combination dose and
10 Gy (Figure 6). However, there exists considerable
heterogeneity among the expression levels of the
different caspases induced by plumbagin and/or
radiation, this could be because of the activation
of specific caspases in a cell specific hierarchical
manner.
Plumbagin and/or Radiation Decreases
Expression of Survivin
Survivin mRNA expression was decreased in HeLa
and C33A cells after treatment with a combination
of 750 nM plumbagin and 2 Gy radiation, when
compared to the expression after treatment with
10 Gy (Figure 7). Survivin mRNA levels in SiHa cells
Figure 1. Analysis of cell viability of cervical cancer cells (HeLa,
SiHa, C33A) after treatment with (A) plumbagin, (B) plumbagin and/
or radiation. (C) Analysis of cell viability of human breast epithelial
cells HBL 100 and human breast adenocarcinoma cells MCF 7 after
treatment with plumbagin. Cells grown in 96-well plates were
then treated with or without the indicated doses for 48 h. Cell
viability was assessed by MTT assay as described in Materials and
Methods. All results are expressed as the mean percentage of
control SD of quadruplicate determinations from three indepen-
dent experiments. The differences among the mean values were
analyzed with one-way ANOVA followed by Tukey post hoc t-test
analysis.
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did not show any remarkable change after the
different treatments.
At the protein level, the expression of Survivin in
C33A cells was much greater than in HeLa and SiHa
cells. Survivinprotein levels, in all the three cell lines,
were decreased as the intensity of the treatment
increased (Figure 8A). However, it was observed that
treatment with plumbagin and/or radiation did not
bring about any pronounced change in the expres-
sion levels of survivin protein when the values
after quantitation were taken into consideration
(Figure 8B).
Plumbagin and/or Radiation Regulates
Expression of Bcl-2 and Bax
Bax is a proapoptoticmember of theBcl-2 family of
proteins. To check whether plumbagin regulates the
expressionofBax in inducing apoptosis,we lookedat
the mRNA level expression by RT-PCR. We observed
that the expression of Bax was the highest when
treated with a combination of 750 nM plumbagin
and 2 Gy radiation in SiHa and HeLa cells, but in
C33A cells Bax expressionwas highest in the samples
treated with 10 Gy radiation (Figure 7).
The protein level expression of Bax was found to
be the highest on treatment with a combination of
750 nM plumbagin and 2 Gy radiation in HeLa cells,
hence confirming the RT-PCR results. Bax protein
expression in C33A cells was the highest on treat-
ment with 10 Gy radiation (Figure 8). Bcl-2 mRNA
and protein expression in HeLa cells was highest on
treatment with a combination of 750 nMplumbagin
and 2 Gy of radiation (Figures 7 and 8) and this
correlates with our MTT assay results.
DISCUSSION
Radiotherapy is a mode of cancer treatment
known to induce cell death in tumors. Radiotherapy
Figure 2. Changes in nuclear morphology induced by plumbagin and/or radiation. (A) HeLa, (B) SiHa and
(C) C33A cells were seeded on 30 mm dishes and then treated as shown in the figure for 12 h. After washing with
phosphate buffered saline, the cells were stained with a mixture of acridine orange–ethidium bromide solutions.
Cells were viewed under fluorescent microscope and photographed (magnification 400) as described under
Materials and Methods. The experiment was repeated twice with similar results. [Color figure can be viewed in the
online issue, which is available at www.interscience.wiley.com.]
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Figure 3. DNA fragmentation induced by plumbagin and/or radiation as determined by TUNEL assay. (A) SiHa,
(B) HeLa and (C) C33A were grown on cover slips and treated as indicated for 12 h. The cells were fixed,
permeabilized with 0.2% Triton X-100, end labeled with Terminal deoxynucleotidyl transferase reaction mix and
the TUNEL reactivity was visualized (magnification 400) as described in Materials and Methods. (D) Quantitation
of apoptotic nuclei was done by counting the cells in random fields and represented as bar diagram. [Color figure
can be viewed in the online issue, which is available at www.interscience.wiley.com.]
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Figure 4. Loss of mitochondrial membrane potential (~m). (A) SiHa, (B) HeLa and (C) C33A. The cells after
treatment were stained with a cationic dye, which aggregates in the mitochondria of healthy cells and fluoresces
red. In apoptotic cells the mitochondrial potential is altered and MitoSensor cannot accumulate in mitochondria
and remain in the cytoplasm and fluoresces green (magnification 400). (D) Quantitation of cells with altered
mitochondrial membrane potential was done by counting the cells in random fields and represented as bar
diagram. [Color figure can be viewed in the online issue, which is available at www.interscience.wiley.com.]
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is limited by the total dose that can be given without
damaging normal tissue. Plumbagin has been
reported to exhibit radiosensitizing properties in
experimental mice [6]. However the underlying
mechanism has not been addressed. Plumbagin has
been reported to possess anticancer activity and to
induce apoptosis in cervical cancer cells by reactive
oxygen species (ROS) generation [11]. Hence we
hypothesized that plumbagin could also have prop-
erties that modify the effects of radiation and
treatment of cervical cancer cells with radiation
alone and in combinationwith plumbaginmay help
in augmenting the anticancer effect of plumbagin.
The effects of plumbagin and/or radiation on three
different cervical cancer cell lines were analyzed.
Plumbagin and radiation inducedcell death inall the
three cell lines in a time and concentration-depen-
dent manner. Cell viability was assayed by the
reduction of MTT at 24 and 48 h after treatment.
The radiosensitizing action of plumbagin was most
pronounced 48 h after treatment (Figure 1). Co-
treatment of plumbagin with radiation was found to
be the most effective in inducing cell death. A
combination of 2 Gy radiation with 750 nM
plumbagin augmented the cell growth inhibition
more effectively than a radiation dose of 10 Gy
(Figure 1B). SiHa and C33A cells were very sensitive
to the combination treatment when compared to a
radiation dose of 10 Gy, but HeLa cells were resistant
to both treatments. The radiosensitizing effect of a
combination of 2 Gy radiation and 750 nM plumba-
gin on the cells could be because of a synergistic
effect. Previous studies have demonstrated sensitiv-
ity to radiation to be enhanced in aspirin pretreated
HeLa TG cells and that aspirin had an additive role
for amplifying the radiotherapeutic effect in cervical
cancer cells [12]. A recent study on cellular response
to chemotherapy and radiation in different cervical
cancer cell lines also showed thatHPVnegativeC33A
was more sensitive to radiation [13]. Our results also
suggest that the radiosensitizing action of plumba-
gin was most effective in the HPV negative C33A
cells. But as of now there is no evidence to suggest
the combined effect of plumbagin with radiation is
Figure 5. Activation of caspase 3, 6, 8 and 9 by plumbagin and/or radiation in (A) SiHa, (B) HeLa and
(C) C33Acells. Cervical cancer cells were treated as indicated for 12 h. Cells were lysed and centrifuged and
the supernatant was used for assaying caspase activity, with substrates for caspase 9 (Ac-LEHD-AFC), caspase 8
(Ac-IETD-AFC), caspase 6 (Ac-VEID-AFC) and caspase 3 (Ac-DEVD-AFC) in a reaction buffer at 378C for 1 h and
caspase activation as described under Materials and Methods. The experiment was repeated another time with
similar results and the caspase activity was expressed as fold activation over the untreated control.
Figure 6. Activation of caspases 3, 8 and 9 by Western blotting.
Lane 1: Control, Lane 2: 2 Gy, Lane 3: 750 nM plumbagin, Lane 4:
750 nM plumbaginþ 2 Gy, Lane 5: 10 Gy. C33A cells were plated in
90 mm dishes and treated as mentioned in Materials and Methods.
Cells were then harvested and whole cell lysates prepared. Fifty
micrograms of the cell lysate was subjected to SDS-PAGE and the
caspases were detected using specific antibodies.
PLUMBAGIN RADIOSENSITIZES CERVICAL CANCER CELLS 29
Molecular Carcinogenesis DOI 10.1002/mc
modulated by the presence of HPV. The cancer
specificity of Plumbagin was also analyzed by treat-
ing human breast epithelial cells, HBL 100 and
human breast adenocarcinoma cells, MCF 7, with
different doses of plumbagin.We could confirm that
plumbagin induced cytotoxicity in MCF 7 cells was
almost 3 times greater than in HBL 100 cells.
Plumbagin has been shown to induce apoptosis in
ME180 cervical cancer cells and BG-1 ovarian cancer
cells [11,14]. To explore themechanism of cell death
in cervical cancer cells by plumbagin and radiation
we studied the induction of apoptosis. Results show
that cell growth inhibition in HeLa, SiHa and C33A
cells, by plumbagin, radiation and a combination of
the two is by apoptosis and thiswas confirmedby the
loss ofmitochondrialmembrane potential (Figure 4)
and TUNEL assay (Figure 3).
Caspases are a family of cysteine proteases that are
activated during the execution phase of the apopto-
tic process [15,16]. Once activated, caspases cleave
and activate downstream caspases [16]. A combina-
tion dose of 750 nM plumbagin and 2 Gy radiation
showed a fivefold increase in the activation of
caspase 3 in C33A cells (Figure 5C). Activation of
caspase 6, 8 and 9 was also greater on combination
treatment when compared to a radiation dose of
10 Gy. In SiHa cells the activation of caspases was
not as marked as in C33A cells, but the activation
of caspases 3, 6, 8 and 9 was greater on treatment
with a combined dose than when treated with 10 Gy
(Figure 5A). Combination treatment in HeLa cells
showed a greater activation of caspase 6 and 8 than
when treated with 10 Gy, whereas there was no
remarkable change in the levels of caspase 9 on all
treatments (Figure 5B). Plumbagin mediated activa-
tionof caspase3andcaspase 9hasbeen shownearlier
in ME180 cervical cancer cells [11]. Recent studies
using Shikonin and Ukrain have shown that HeLa
cell apoptosis is induced through the activation of
caspases [17,18]. K562 cells treated with radiation
and herbimycin A had an accelerated cell death and
induceda p53 independent apoptosis. This apoptotic
Figure 7. (A) RT-PCR analysis of mRNA expression of Bcl-2, Bax, Survivin and b-2-microglobulin in HeLa, SiHa
and C33A cells. Lane 1: Control, Lane 2: 2 Gy, Lane 3: 750 nM plumbagin, Lane 4 750 nM plumbaginþ 2 Gy, Lane
5: 10 Gy. (B) Bands of interest were further analyzed by densitometry. Total RNA was extracted from the cells
treated with plumbagin and/or radiation for 12 h. Five micrograms of RNA was used for RT-PCR. Expression values
for each PCR product were normalized to their respective b-2-microglobulin expression.
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pathway was dependent upon an initial hyperpolar-
ization of the mitochondrial inner membrane,
following the release of cytochrome c and subse-
quent caspase 3 activation [19].Our results also show
the involvement of the caspase-dependent pathways
of apoptosis. There exists considerable heterogeneity
among the expression levels of the different caspases
induced by plumbagin and/or radiation (Figure 6),
this could be because of the activation of specific
caspases in a cell specific hierarchical manner.
Apart from the activation of caspases we also
studied the expression of survivin. Survivin has
recently been identified as a novel member of the
inhibitor of apoptosis (IAP) gene family. The product
of this gene not only suppresses apoptosis but also
controls cell division. Survivin is undetectable in
most terminally differentiated normal tissues but is
expressed in embryonic and fetal organs and is
present in most malignant tumors [20]. Survivin
mRNA expression was decreased in HeLa and C33A
cells after treatment with a combination of 750 nM
plumbagin and 2 Gy radiation, when compared to
the expression after treatment with 10 Gy (Figure 7).
Plumbagin has been shown to downregulate the
expression of survivin [21]. Plumbagin and radiation
treatment reduced theexpressionof survivin in all the
three cell lines, showing an increased susceptibility
for apoptosis to occur. Therefore induction of
apoptosis and inhibition of IAPs may be a mechan-
ism of action of plumbagin with radiation.
Human papilloma viruses are thought to play an
important role in the development of cervical cancer
[22]. By interfering in the cell cycle, the viral
oncoproteins (E6 and E7) can induce the immorta-
lization of the host cell. Experiments performed in
different cancer cell lines and with different E6
mutants indicated that the effect of E6 on the
survivin promoter is largely dependent on p53
status. As E6 is able to interact with p53 and induces
its ubiquitin-dependent degradation, it appears that
the transactivation effect of E6 on survivin is
mediated by the p53 degradation pathway [20].
Studies on sarcoma cells suggest that the wt-p53-
caspase pathway is of importance for the radio-
sensitization induced by targeting survivin, which
may have an impact on future gene therapeutical
treatments [23].
Members of thegene family that includesBcl-2 and
Bax are involved in thecontrol of apoptosis ina range
of different cell types. The ability of Bcl-2 to inhibit
Figure 8. (A) Expression of Bcl-2, Bax and Survivin by Western blotting. Lane 1: Control, Lane 2: 2 Gy, Lane 3:
750 nM plumbagin, Lane 4: 750 nM plumbaginþ2 Gy, Lane 5: 10 Gy. (B) Bands of interest were further analyzed
by densitometry. Cells were plated in 90 mm dishes and treated as mentioned in Materials and Methods. Cells were
then harvested and whole cell lysates prepared. Fifty micrograms of the cell lysate was subjected to SDS-PAGE and
the proteins were detected using specific antibodies. The same blot was reprobed with b-actin antibody. Bands
were analyzed by densitometry and normalized to b-actin expression.
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apoptosis is dependent on expression of Bcl-2 and on
the formation of hetero- and homodimers between
members of the Bcl-2 family [24]. On the other hand,
the BAX gene is an apoptosis-promoting member of
the BCL-2 gene family, and apoptosis is known to be
accelerated when the BAX function is predominant
[25]. Our results show marginal changes in the
expression levels of Bcl-2 and Bax in all the three cell
lines (Figures 7 and 8). It has been observed that
unchanged expression of the pro-apoptotic protein
Bax and suppression of the anti-apoptoticmolecules
Bcl-2 and Bcl-x (L) argues for the engagement of the
mitochondrial apoptotic pathway [26].
To summarize, our results show that a combina-
tion of plumbagin and radiation augmented cell
growth inhibition when compared to a higher
radiation dose, thus indicating that plumbagin may
be a potential radiosensitizer. C33A cells were found
to be the most sensitive to the combination treat-
ment. This is the first report confirming the radio-
sensitizing action of plumbagin in cervical cancer
cells. Plumbagin induces apoptosis in all the three
cervical cancer cells via the caspase-dependent path-
ways. The documented effect may also be because of
the inhibition of survivin levels. Our study shows
that although cell growth inhibition is highest in
combination treatment, mechanism of action is
different in each cell line owing to their molecular
alterations. The results from the three cell lines
varied with respect to the expression of various
proteins in response to plumbagin, radiation and
its combination. Therefore, in vivo tumors (more
heterogenic) may behave much differently and a lot
more studies have to be done before any work could
be planned in an animal model of cervical cancer.
Nevertheless this study shows the potential of
plumbagin in augmenting radiation effects.
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